otssp167 and Multiple-Myeloma

otssp167 has been researched along with Multiple-Myeloma* in 1 studies

Other Studies

1 other study(ies) available for otssp167 and Multiple-Myeloma

Article	Year
Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells. Blood cancer journal, 2016, 08-19, Volume: 6, Issue:8 Topics: Antineoplastic Agents; Bone Marrow Cells; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Multiple Myeloma; Naphthyridines; Neoplastic Stem Cells; Plasma Cells; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Tumor Microenvironment	2016

Article

Year

Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells.

Blood cancer journal, 2016, 08-19, Volume: 6, Issue:8

Topics: Antineoplastic Agents; Bone Marrow Cells; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Multiple Myeloma; Naphthyridines; Neoplastic Stem Cells; Plasma Cells; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Tumor Microenvironment

2016